Corvus Pharmaceuticals
CRVS
#6513
Rank
NZ$1.49 B
Marketcap
NZ$17.68
Share price
-3.40%
Change (1 day)
15.82%
Change (1 year)

Earnings for Corvus Pharmaceuticals (CRVS)

Earnings in 2026 (TTM): -NZ$94.23 Million

According to Corvus Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$27.94 Million, an increase over its 2024 earnings that were of -NZ$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corvus Pharmaceuticals from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$94.23 Million237.29%
2025 -NZ$27.94 Million-75.47%
2024 -NZ$0.12 Billion130.47%
2023 -NZ$49.41 Million-34.57%
2022 -NZ$75.51 Million-4.47%
2021 -NZ$79.05 Million621.28%
2020 -NZ$10.96 Million-87.16%
2019 -NZ$85.32 Million-0.57%
2018 -NZ$85.81 Million-15.67%
2017 -NZ$0.11 Billion53.03%
2016 -NZ$66.5 Million16.08%
2015 -NZ$57.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.29 Billion 188.45%๐Ÿ‡บ๐Ÿ‡ธ USA